Article
Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study.
Journal of gynecologic oncology - 1 May 2022
Yu Shuangni, Sun Zezheng, Zong Liju, Yan Jie, Yu Mei, Chen Jie, Lu Zhaohui
Abstract excerpt
OBJECTIVE: The molecular classification system of endometrial carcinoma (EC) in 'The Cancer Genome Atlas' is widely acknowledged for its prognostic utility. Subsequently, more simplified classification system that incorporate DNA polymerase epsilon (POLE) exonuclease domain mutations, mismatch repair deficiencies (MMRd), and abnormal p53 (P53abn) has also demonstrated its clinical utility. These classifications...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
